No data to show
OTCM
CMRA
Market cap6kUSD
May 27, Last price
0.00USD
IPO
-100.00%
Name
Comera Life Sciences Holdings Inc
Chart & Performance
P/E
—
P/S
0.01
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
633k
+97.95%
Net income
-24m
L+354.31%
CFO
-10m
L+160.03%
Profile
As of May 19, 2022, OTR Acquisition Corp. was acquired by Comera Life Sciences Holdings, Inc., in a reverse merger transaction. OTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.
IPO date
Dec 15, 2020
Employees
12
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||
Revenues | 633 97.95% | ||
Cost of revenue | 12,603 | ||
Unusual Expense (Income) | |||
NOPBT | (11,970) | ||
NOPBT Margin | |||
Operating Taxes | 6,034 | ||
Tax Rate | |||
NOPAT | (18,004) | ||
Net income | (24,038) 354.31% | ||
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | 650,829 | ||
BB yield | |||
| Debt | |||
Debt current | 655 | ||
Long-term debt | 440 | ||
Deferred revenue | |||
Other long-term liabilities | 4,795 | ||
Net debt | 648 | ||
| Cash flow | |||
Cash from operating activities | (9,772) | ||
CAPEX | (29) | ||
Cash from investing activities | (29) | ||
Cash from financing activities | 5,242 | ||
FCF | (16,680) | ||
| Balance | |||
Cash | 447 | ||
Long term investments | |||
Excess cash | 415 | ||
Stockholders' equity | 4,482,808 | ||
Invested Capital | (1,092) | ||
ROIC | |||
ROCE | 1,768.56% | ||
| EV | |||
Common stock shares outstanding | 10,453 | ||
Price | |||
Market cap | |||
EV | |||
EBITDA | (11,876) | ||
EV/EBITDA | |||
Interest | 20 | ||
Interest/NOPBT | |||